tradingkey.logo
tradingkey.logo
Suchen

LeMaitre Vascular Inc

LMAT
Zur Watchlist hinzufügen
98.740USD
+2.780+2.90%
Handelsschluss 07/01, 16:00ETKurse um 15 Minuten verzögert
2.25BMarktkapitalisierung
35.90KGV TTM

mehr Informationen über LeMaitre Vascular Inc Unternehmen

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.

LeMaitre Vascular Inc Informationen

BörsenkürzelLMAT
Name des UnternehmensLeMaitre Vascular Inc
IPO-datumOct 19, 2006
CEOLemaitre (George W)
Anzahl der mitarbeiter651
WertpapierartOrdinary Share
GeschäftsjahresendeOct 19
Addresse63 2nd Ave
StadtBURLINGTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01803
Telefon17812212266
Websitehttps://www.lemaitre.com/
BörsenkürzelLMAT
IPO-datumOct 19, 2006
CEOLemaitre (George W)

Führungskräfte von LeMaitre Vascular Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
President, Director
President, Director
6.68K
-108.68%
Mr. Lawrence J. (Larry) Jasinski
Mr. Lawrence J. (Larry) Jasinski
Independent Director
Independent Director
3.19K
-33.98%
Mr. Trent G. Kamke
Mr. Trent G. Kamke
Senior Vice President - Operations
Senior Vice President - Operations
2.24K
-198.61%
Ms. Martha Shadan
Ms. Martha Shadan
Independent Director
Independent Director
1.44K
-105.55%
Mr. George W. Lemaitre
Mr. George W. Lemaitre
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Joseph P. Pellegrino, Jr.
Mr. Joseph P. Pellegrino, Jr.
Director
Director
--
--
Mr. John J. O'Connor
Mr. John J. O'Connor
Independent Director
Independent Director
--
--
Ms. Kimberly L. Cieslak
Ms. Kimberly L. Cieslak
Vice President - Marketing
Vice President - Marketing
--
--
Mr. Ryan H. Connelly
Mr. Ryan H. Connelly
Senior Vice President - Advanced Manufacturing Engineering
Senior Vice President - Advanced Manufacturing Engineering
--
--
Mr. Maik D. Helmers
Mr. Maik D. Helmers
Senior Vice President - Sales, Central Europe
Senior Vice President - Sales, Central Europe
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
President, Director
President, Director
6.68K
-108.68%
Mr. Lawrence J. (Larry) Jasinski
Mr. Lawrence J. (Larry) Jasinski
Independent Director
Independent Director
3.19K
-33.98%
Mr. Trent G. Kamke
Mr. Trent G. Kamke
Senior Vice President - Operations
Senior Vice President - Operations
2.24K
-198.61%
Ms. Martha Shadan
Ms. Martha Shadan
Independent Director
Independent Director
1.44K
-105.55%
Mr. George W. Lemaitre
Mr. George W. Lemaitre
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Joseph P. Pellegrino, Jr.
Mr. Joseph P. Pellegrino, Jr.
Director
Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von LeMaitre Vascular Inc?

Die fünf größten Anteilseigner von LeMaitre Vascular Inc sind: Mr. David Brian (Dave) Roberts

Wie viele Institutionen halten Anteile an LeMaitre Vascular Inc (LMAT)?

Mit Stand vom 2026Q1 halten 614 Institutionen Anteile an LeMaitre Vascular Inc, mit einem Gesamtmarktwert von etwa 23.53M, was 102.98% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 853773.00 gestiegen.